4//SEC Filing
Yea Christopher 4
Accession 0001691102-25-000004
CIK 0001348911other
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 4:07 PM ET
Size
7.1 KB
Accession
0001691102-25-000004
Insider Transaction Report
Form 4
Yea Christopher
CHIEF DEVELOPMENT OFFICER
Transactions
- Exercise/Conversion
Common Stock
2025-11-20$0.00/sh+87,390$376→ 220,964 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2025-11-20−87,390→ 0 totalExercise: $0.00Exp: 2026-03-30→ Common Stock (87,390 underlying)
Footnotes (1)
- [F1]This option is 100% vested and exercised.
Documents
Issuer
KalVista Pharmaceuticals, Inc.
CIK 0001348911
Entity typeother
Related Parties
1- filerCIK 0001691102
Filing Metadata
- Form type
- 4
- Filed
- Nov 20, 7:00 PM ET
- Accepted
- Nov 21, 4:07 PM ET
- Size
- 7.1 KB